8-K Announcements
6Material company update
May 20, 2026·SEC
Material company update
May 14, 2026·SEC
Material company update
Apr 23, 2026·SEC
SBC Medical Group Holdings Incorporated(SBC)Earnings, Financials & Key Ratios
SBC•NASDAQ
$2.96
5.9× P/E·Price updated Jul 7, 2026
AboutSBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.Show more
- Revenue$174M-15.5%
- EBITDA$70M-5.3%
- Net Income$51M+9.4%
- EPS (Diluted)0.50+4.2%
- Gross Margin73.32%-3.5%
- EBITDA Margin40.42%+12.0%
- Operating Margin38.87%+13.6%
- Net Margin29.37%+29.4%
- ROE22.25%-19.1%
SBC Price & Volume
SBC Medical Group Holdings Incorporated (SBC) stock price & volume — 10-year historical chart
Loading chart...
Persistent Revenue Contraction Challenges Aesthetic Business Model
Investment Thesis • Updated 2026Q1
VerdictNegative: The company's inability to sustain revenue growth
Growth:Contracting
Profitability:Moderate
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Persistent Revenue Contraction
Key Thesis Takeaways
- SBC Medical Group faces significant headwinds as evidenced by a 9.0% year-over-year revenue decline in 2026Q1, signaling potential saturation or competitive pressure within its core Japanese aesthetic management services.
- While the company maintains a robust liquidity position with $167.3M in cash, the lack of consistent operating leverage and erratic net income volatility suggest that the current franchise model struggles to scale profitably.
- Investors should remain cautious until the company demonstrates a clear path to stabilizing its top-line growth and improving the predictability of its cash conversion cycles.
Verdict Logic
evidenced by the recent 9.0% contraction, combined with erratic free cash flow margins, suggests significant operational risks that outweigh the current 6.52 P/E valuation.
SBC Growth Metrics
SBC Medical Group Holdings Incorporated (SBC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-0.11%
TTM-14.45%
Profit CAGR
10 Years-
5 Years-
3 Years100.61%
TTM-17.36%
EPS CAGR
10 Years-
5 Years-
3 Years99.79%
TTM-21.77%
Return on Capital
10 Years32.11%
5 Years32.11%
3 Years37.42%
Last Year25.75%
SBC Recent Earnings
SBC Medical Group Holdings Incorporated (SBC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (57%)●Beat Revenue 2/12 qtrs (29%)
Q2 2026Latest
May 14, 2026Metric
Actual
Est
EPS
$0.11+10.0%
$0.10
Rev
$43M+3.4%
$42M
Q2 2026
Mar 27, 2026Metric
Actual
Est
EPS
$0.14+7.7%
$0.13
Rev
$40M-12.9%
$45M
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.12-7.7%
$0.13
Rev
$43M-4.1%
$45M
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.02-85.7%
$0.14
Rev
$43M-5.0%
$46M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 14, 2026 | $0.11vs $0.10+10.0% | $43Mvs $42M+3.4% |
| Q2 2026 | Mar 27, 2026 | $0.14vs $0.13+7.7% | $40Mvs $45M-12.9% |
| Q4 2025 | Nov 14, 2025 | $0.12vs $0.13-7.7% | $43Mvs $45M-4.1% |
| Q3 2025 | Aug 13, 2025 | $0.02vs $0.14-85.7% | $43Mvs $46M-5.0% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for SBC Medical Group Holdings Incorporated (SBC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.96 | $304.43M | 5.92 | -15.48% | 29.37% | 22.25% | — | |
| $1.11 | $143.86M | -6.94 | -10.02% | -2.03% | -9.41% | — | |
| $14.54 | $921.24M | 10.17 | -6.16% | 23.27% | 13.28% | — | |
| $0.12 | $705.41K | -0.09 | -8.54% | -21.13% | -360.33% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $1.30 | $22.27M | -1.27 | 131.96% | -268.71% | -4407.08% | — |
Compare SBC vs Peers
SBC Medical Group Holdings Incorporated (SBC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SBC SEC Filings & Documents
SBC Medical Group Holdings Incorporated (SBC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when SBC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SBC Frequently Asked Questions
SBC Medical Group Holdings Incorporated (SBC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is SBC Medical Group Holdings Incorporated's revenue?
SBC Medical Group Holdings Incorporated (SBC) reported $169.3M in revenue for fiscal year 2025. This represents a 3% decrease from $174.2M in 2022.
How fast is SBC Medical Group Holdings Incorporated growing?
SBC Medical Group Holdings Incorporated (SBC) saw revenue decline by 15.5% over the past year.
Is SBC profitable?
Yes, SBC Medical Group Holdings Incorporated (SBC) is profitable, generating $40.8M in net income for fiscal year 2025 (29.4% net margin).
Dividend & Returns
What is SBC's return on equity?
SBC Medical Group Holdings Incorporated (SBC) has a return on equity (ROE) of 22.2%. This is excellent, indicating efficient use of shareholder capital.
What is SBC Medical Group Holdings Incorporated's free cash flow?
SBC Medical Group Holdings Incorporated (SBC) generated $44.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.